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II. Supplementary Methods
Synthesis of TreAz analogues
4,6-O-Cyclohexylidene-3-O-methoxymethyl-α-D-mannopyranosyl-(1→1)-2,3;4,6-di-Ocyclohexylidene-α-D-glucopyranoside (7)
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2-O-Benzoyl-4,6-O-cyclohexylidene-α-D-allopyranosyl-(1→1)-2,3;4,6-di-O-cyclohexylidene-α-D-glucopyranoside (9)
O
3-Azido-2-O-benzoyl-4,6-O-cyclohexylidene-3-deoxy-α-D-glucopyranosyl-(1→1)-2,3;4,6-di-
O-cyclohexylidene-α-D-glucopyranoside (4)
Isocratic elution was performed using H 2 O (76%) and 2 M NaOH (24%) for a final eluent concentration of 480 mM NaOH at a flow rate of 0.4 mL/min. For standards (prepared at 10 µg/mL), trehalose was purchased (Sigma Aldrich) and TreAz analogues were synthesized as described above. Chromeleon 7 software (Dionex) was used for data processing. 
